THYROID GLAND ONCOCYTIC CARCINOMA

Clinical trials for THYROID GLAND ONCOCYTIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new THYROID GLAND ONCOCYTIC CARCINOMA trials appear

Sign up with your email to follow new studies for THYROID GLAND ONCOCYTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug combo aims to boost Cancer-Killing power of radiation

Disease control Recruiting now

This study is testing whether taking two oral drugs (vemurafenib and cobimetinib) before standard radioactive iodine treatment can improve outcomes for patients with high-risk thyroid cancer that has a specific genetic change (BRAFV600E mutation). The goal is to see if these drug…

Matched conditions: THYROID GLAND ONCOCYTIC CARCINOMA

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Apr 01, 2026 18:41 UTC

THYROID GLAND ONCOCYTIC CARCINOMA

Get alerted when new THYROID GLAND ONCOCYTIC CARCINOMA trials appear

New drug combo aims to boost Cancer-Killing power of radiation